Dysregulation of FOXG1 pathway in a 14q12 microdeletion case.

Am J Med Genet A

UMR7355, CNRS, Orleans, France; Experimental and Molecular Immunology and Neurogenetics, University of Orleans, Orleans, France; Genetic Department, Regional Hospital, Orleans, France.

Published: December 2013

"FOXG1 syndrome" includes postnatal microcephaly, severe intellectual disability with absence of language and agenesis of the corpus callosum. When the syndrome is associated with large 14q12q13 deletions, the patients present characteristic facial dysmorphism. Although all reports were based on genomic analysis, recently a FOXG1 regulatory elements deletion, associated with down regulated mRNA, suggested an implication of FOXG1 pathway. Herein, we report on a young boy with a phenotype consistent with a FOXG1 syndrome. He had a de novo translocation t(6;14)(q22.1;q12) associated with a heterozygous 14q12.2q13 deletion encompassing FOXG1. Subsequently, we investigated his transcriptomic profile on lymphoblastoïd cell lines and/or fibroblasts and showed that FOXG1 was commonly down-regulated. Moreover, several other FOXG1 pathway genes were also disturbed. Our data and review of previous reports highlight dysregulation of FOXG1 pathway as the cause of the "FOXG1 syndrome" developmental disorder.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36170DOI Listing

Publication Analysis

Top Keywords

foxg1 pathway
16
dysregulation foxg1
8
"foxg1 syndrome"
8
foxg1
7
pathway
4
pathway 14q12
4
14q12 microdeletion
4
microdeletion case
4
case "foxg1
4
syndrome" includes
4

Similar Publications

GABA/Glutamate Neuron Differentiation Imbalance and Increased AKT/mTOR Signaling in CNTNAP2 Cerebral Organoids.

Biol Psychiatry Glob Open Sci

January 2025

Biomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, Ioannina, Greece.

Background: The polygenic nature of autism spectrum disorder (ASD) requires the identification of converging genetic pathways during early development to elucidate its complexity and varied manifestations.

Methods: We developed a human cerebral organoid model from induced pluripotent stem cells with targeted genome editing to abolish protein expression of the ASD risk gene.

Results: CNTNAP2 cerebral organoids displayed accelerated cell cycle, ventricular zone disorganization, and increased cortical folding.

View Article and Find Full Text PDF

Modelling quiescence exit of neural stem cells reveals a FOXG1-FOXO6 axis.

Dis Model Mech

December 2024

Centre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.

The molecular mechanisms controlling the balance of quiescence and proliferation in adult neural stem cells (NSCs) are often deregulated in brain cancers such as glioblastoma multiforme (GBM). Previously, we reported that FOXG1, a forebrain-restricted neurodevelopmental transcription factor, is frequently upregulated in glioblastoma stem cells (GSCs) and limits the effects of cytostatic pathways, in part by repression of the tumour suppressor Foxo3. Here, we show that increased FOXG1 upregulates Foxo6, a more recently discovered FOXO family member with potential oncogenic functions.

View Article and Find Full Text PDF

Age-related hearing loss (AHL) is a prevalent and multifaceted condition that significantly impacts a substantial portion of the aging population. Oxysterol Binding Protein-like 2 (OSBPL2) has been identified as a causal gene for hearing loss. However, its role in AHL is still unclear.

View Article and Find Full Text PDF

Drug repurposing in Rett and Rett-like syndromes: a promising yet underrated opportunity?

Front Med (Lausanne)

July 2024

Department of Pediatrics, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands.

Rett syndrome (RTT) and Rett-like syndromes [i.e., CDKL5 deficiency disorder (CDD) and FOXG1-syndrome] represent rare yet profoundly impactful neurodevelopmental disorders (NDDs).

View Article and Find Full Text PDF

Background: Prostate cancer (PCa), a prevalent malignancy worldwide, is frequently identified in advanced stages due to the absence of distinctive early symptoms, thereby culminating in the development of chemotherapy-induced drug resistance. Exploring novel resistance mechanisms and identifying new therapeutic agents can facilitate the advancement of more efficacious strategies for PCa treatment.

Methods: Bioinformatics analysis was employed to investigate the expression of FOXG1 in PCa tissues.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!